Main Menu

Defeating cancer – whatever form it takes

The Institute of Cancer Research, London conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.

The pages listed below highlight the latest news about our research into specific types of cancer. They also provide a broad overview of our expertise in each area, as well as provide links to relevant researchers and clinical trials.

Bowel cancer

Our researchers are working to deliver real benefits for people with bowel cancer (also known as colorectal cancer).

Find out more

Brain cancer

Our researchers have been responsible for making some breakthrough discoveries in brain cancer.

Find out more

Breast cancer

Learn how the ICR is tackling the most common type of cancer among women, which affects around one in eight women in their lifetime.

Find out more

Cervical cancer

Scientists at the ICR have worked on improving imaging technology that helps guide decision-making in surgery, and helped trial new drugs in patients with cervical cancer.

Find out more

Childhood cancers

The ICR is an internationally leading research centre in the study of childhood cancers and cancers in children, teenagers and young adults.

Find out more

Kidney cancer

Our scientists conduct world-class clinical and translational research to benefit kidney cancer patients.

Find out more


ICR scientists are at the forefront of research to better understand the skin cancer melanoma.

Find out more

Ovarian cancer

Our research greatly impacts on ovarian cancer treatment, including better diagnostic and risk testing, development of new drugs and new targeted treatments.

Find out more

Pancreatic cancer

Our work includes researching which genes are involved in pancreatic cancer and finding new ways of matching treatments to specific types of the disease.

Find out more

Prostate cancer

Our wide-ranging programme of prostate cancer research is helping men to live longer, improving their quality of life and increasing cure rates.

Find out more